According to Lannett Company's latest financial reports the company's total liabilities are $0.74 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-06-30 | $0.73 B | 3.42% |
2021-06-30 | $0.71 B | -14.69% |
2020-06-30 | $0.83 B | -2.31% |
2019-06-30 | $0.85 B | -12.6% |
2018-06-30 | $0.97 B | -6.31% |
2017-06-30 | $1.04 B | -13.84% |
2016-06-30 | $1.20 B | 2587.91% |
2015-06-30 | $45 M | -6.27% |
2014-06-30 | $48 M | 23.28% |
2013-06-30 | $38.94 M | -16.97% |
2012-06-30 | $46.9 M | 11.53% |
2011-06-30 | $42.05 M | -17.55% |
2010-06-30 | $51 M | 8.69% |
2009-06-30 | $46.92 M | -1.28% |
2008-06-30 | $47.53 M | 37.9% |
2007-06-30 | $34.47 M | 14.01% |
2006-06-30 | $30.23 M | 17.8% |
2005-06-30 | $25.66 M | 23.57% |
2004-06-30 | $20.77 M | 178.27% |
2003-06-30 | $7.46 M | 7.52% |
2002-06-30 | $6.94 M | -47.21% |
2001-06-30 | $13.14 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 13,126.17% | ๐บ๐ธ USA |
Novartis NVS | $54.57 B | 7,207.44% | ๐จ๐ญ Switzerland |
Pfizer PFE | $137.21 B | 18,271.42% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $34.38 B | 4,504.07% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $58.82 B | 7,776.11% | ๐ฌ๐ง UK |